{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:09:04Z","timestamp":1787159344598,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007496","name":"Veterans Health Administration Biomedical Laboratory Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019102","name":"Cancer Center, University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbadis.2023.166913","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T11:24:34Z","timestamp":1696677874000},"page":"166913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling"],"prefix":"10.1016","volume":"1870","author":[{"given":"Sumit","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insug","family":"O-Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne K.","family":"Tobacman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbadis.2023.166913_bb0005","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.18632\/oncotarget.13751","article-title":"Decline in arylsulfatase B leads to increased invasiveness of melanoma cells","volume":"8","author":"Bhattacharyya","year":"2017","journal-title":"Oncotarget."},{"issue":"33","key":"10.1016\/j.bbadis.2023.166913_bb0010","first-page":"20150","article-title":"Sequential degradation of chondroitin sulfate in molluscs","volume":"265","author":"de Sousa","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166913_bb0015","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/S0021-9258(17)30223-5","article-title":"Chondroitin SO4 catabolism in chick embryo chondrocytes","volume":"254","author":"Glaser","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166913_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/bj1790007","article-title":"Sequential degradation of a chondroitin sulfate disaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage","volume":"179","author":"Ingmar","year":"1979","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166913_bb0025","first-page":"1811","article-title":"Arylsulphatase B, an exo-sulphatase for chondroitin 4-sulphate tetrasaccharide","volume":"359","author":"Gorham","year":"1978","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.bbadis.2023.166913_bb0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0008-6215(00)90341-0","article-title":"The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation","volume":"151","author":"Cogburn","year":"1986","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbadis.2023.166913_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment","volume":"22","author":"Harmatz","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"21","key":"10.1016\/j.bbadis.2023.166913_bb0040","doi-asserted-by":"crossref","first-page":"13146","DOI":"10.3390\/ijms232113146","article-title":"Profound impact of decline in N-acetyflgalactosamine-4-sulfatase (arylsulfatase B) on molecular pathophysiology and human diseases","volume":"23","author":"Tobacman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166913_bb0045","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/onc.2013.483","article-title":"Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects","volume":"33","author":"Bhattacharyya","year":"2014","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166913_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033250","article-title":"Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia","volume":"7","author":"Bhattacharyya","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2023.166913_bb0055","doi-asserted-by":"crossref","first-page":"17564","DOI":"10.1074\/jbc.M114.561589","article-title":"Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3","volume":"289","author":"Bhattacharyya","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166913_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ijc.2910280307","article-title":"Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies","volume":"8","author":"Wilson","year":"1981","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2023.166913_bb0065","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1755-148X.2011.00929.x","article-title":"CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma","volume":"24","author":"Price","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166913_bb0070","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41467-023-37811-3","article-title":"Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4","volume":"14","author":"Chauhan","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166913_bb0075","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/cancers11081198","article-title":"Clinical-scale production of CAR-T cells for the treatment of melanoma patients by mRNA transfection of a CSPG4-specific CAR under full GMP compliance","volume":"11","author":"Wiesinger","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166913_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004007","article-title":"Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial","volume":"10","author":"Riccardo","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166913_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3892\/ijo.2021.5250","article-title":"A chondroitin sulfate proteoglycan 4-specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model","volume":"59","author":"Uranowska","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166913_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153463","article-title":"Inhibition of phosphatase activity follows decline in sulfatase activity and leads to transcriptional effects through sustained phosphorylation of transcription factor MITF","volume":"11","author":"Bhattacharyya","year":"2015","journal-title":"PloS One"},{"issue":"59","key":"10.1016\/j.bbadis.2023.166913_bb0095","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.18632\/oncotarget.22152","article-title":"Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1\/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)","volume":"8","author":"Bhattacharyya","year":"2017","journal-title":"Oncotarget."},{"issue":"28","key":"10.1016\/j.bbadis.2023.166913_bb0100","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1074\/jbc.RA117.001244","article-title":"Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells","volume":"293","author":"Bhattacharyya","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166913_bb0105","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.18632\/oncotarget.27634","article-title":"Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity","volume":"11","author":"Bhattacharyya","year":"2020","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166913_bb0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41388-021-02109-5","article-title":"MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis","volume":"41","author":"Shin","year":"2022","journal-title":"Oncogene."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166913_bb0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/cells9051151","article-title":"Functional roles of matrix metalloproteinases and their inhibitors in melanoma","volume":"9","author":"Napoli","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.bbadis.2023.166913_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13402-012-0080-x","article-title":"MMP2 expression is a prognostic marker for primary melanoma","volume":"35","author":"Rotte","year":"2012","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bbadis.2023.166913_bb0125","first-page":"37","article-title":"Gelatinase-mediated migration and invasion of cancer cells","volume":"2005","author":"Yang","year":"1755","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2023.166913_bb0130","first-page":"37","article-title":"Gelatinase-mediated migration and invasion of cancer cells","volume":"2005","author":"Bj\u00f6rklund","year":"1755","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2023.166913_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejcb.2014.01.002","article-title":"Metalloproteinases in melanoma","volume":"93","author":"Moro","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbadis.2023.166913_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biochi.2005.01.013","article-title":"Role of matrix metalloproteinases in melanoma cell invasion","volume":"8","author":"Hofmann","year":"2005","journal-title":"Biochimie."},{"key":"10.1016\/j.bbadis.2023.166913_bb0145","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.1636","article-title":"High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma","volume":"97","author":"Nikkola","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2023.166913_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jnci\/86.4.299","article-title":"Suppression of the tumourigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1","volume":"86","author":"Khokha","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2023.166913_bb0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1248\/bpb.20.843","article-title":"Antimetastatic and antitumour effect of a recombinant human tissue inhibitor of metalloproteinases-2 in murine melanoma models","volume":"20","author":"Oku","year":"1997","journal-title":"Biol. Pharm. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2023.166913_bb0160","first-page":"81","article-title":"Current state of animal (mouse) modeling in melanoma research","volume":"8","author":"OF","year":"2015","journal-title":"Cancer Growth Metastasis."},{"key":"10.1016\/j.bbadis.2023.166913_bb0165","author":"Biocolor Ltd"},{"key":"10.1016\/j.bbadis.2023.166913_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2008.05.190","article-title":"Desulfated galactosaminoglycans are potential ligands for galectins: evidence from frontal affinity chromatography","volume":"373","author":"Iwaki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166913_bb0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/glycob\/cwac030","article-title":"Functions of chondroitin\/dermatan sulfate containing GalNAc4,6-disulfate","volume":"32","author":"Habuchi","year":"2022","journal-title":"Glycobiology."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166913_bb0180","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","article-title":"Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance","volume":"167","author":"Li","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.bbadis.2023.166913_bb0185","doi-asserted-by":"crossref","first-page":"9582714","DOI":"10.1155\/2019\/9582714","article-title":"Distinct effects of carrageenan and high fat consumption on mechanisms of insulin resistance in non-obese and obese models of type 2 diabetes","volume":"2019","author":"Bhattacharyya","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"44","key":"10.1016\/j.bbadis.2023.166913_bb0190","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","article-title":"Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease","volume":"271","author":"Yogalingam","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166913_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:11:3:223","article-title":"Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat","volume":"11","author":"Jones","year":"1998","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166913_bb0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2013.213","article-title":"Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage disease","volume":"25","author":"Ferla","year":"2014","journal-title":"Hum Gene Ther."}],"updated-by":[{"DOI":"10.1016\/j.bbadis.2024.167231","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:15:48Z","timestamp":1735690548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392300279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S092544392300279X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166913","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.30.542851","asserted-by":"object"}]},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166913"}}